Moms with rheumatoid arthritis more likely to give birth prematurely

November 13, 2014

Researchers from Denmark and the U.S. report that babies of women with rheumatoid arthritis (RA) or pre-clinical RA--the period prior to symptoms--are 1.5 times more likely to be born prematurely in Denmark. Findings published in Arthritis & Rheumatology, a journal of the American College of Rheumatology (ACR), indicate that body measurements of the baby at birth were only slightly lower in children exposed to maternal or preclinical RA compared to those with no exposure to the disease. Paternal RA was not found to impact fetal growth or preterm birth risk.

Roughly one percent of individuals worldwide have RA, a systemic autoimmune disease that causes chronic inflammation of the joints. In the U.S., the Arthritis Foundation estimates that 1.5 million people have RA, which affects three times as many women as men. Previous studies have linked rheumatic diseases in mothers with a variety of pregnancy complications including preterm birth and low birth weight in babies. However, there is limited evidence examining the impact of RA or preclinical RA, specifically, on pregnancy outcomes.

Led by Ane Rom, MPH, from Copenhagen University Hospital in Denmark, the present nationwide study used national registries to identify all children born (singleton births) in Denmark between 1977 and 2008. After excluding for multiple child births, children adopted, or those who could not be linked to their mother, researchers had a final study group of 1,917,723 children.

Results show that 13,566 children were exposed to maternal RA (mother was diagnosed prior to giving birth) or preclinical RA (mother diagnosed after giving birth). Children (2,101) born to mothers with RA had similar measurements--birth length, head and abdominal circumference--at birth compared with babies of mothers without RA. In mothers with RA, birth weight of the baby was 87 grams (3oz) lower and placenta weight was 14 grams (0.5oz) lower than babies born to mothers without the disease. Researchers found rather similar results in children (11,455) exposed to preclinical RA.

Compared with unexposed children, researchers determined preterm birth risk was higher in children exposed to maternal RA and pre-clinical RA with an odds ratio of 1.48 and 1.32, respectively. "Obstetricians should be aware of the increased risk of preterm birth in women with RA and among those with preclinical signs of the disease," advises Ms. Rom.

Rom adds, "For women with RA, we found only a small reduction in fetal growth in their babies, which has little impact on the children immediately following birth. The long term health effects for children born to mothers with RA need further investigation."
-end-
This study was funded by grants from the National Institute of Health (5R21AR059931- 02), The Danish Council for Independent Research and The Augustinus Foundation.

This study is published in Arthritis & Rheumatology. Media wishing to receive a PDF of this article may contact sciencenewsroom@wiley.com.

Full citation: "Fetal Growth and Preterm Birth in Children Exposed to Maternal or Paternal Rheumatoid Arthritis: A Nationwide Cohort Study." Ane L Rom, Chun S Wu, Jorn Olsen, Hanne Kjargaard, Damini Jawaheer, Merete L Hetland, Mogens Vestergaard and Lina S Morch. Arthritis & Rheumatology; Published Online: November 13, 2014 (DOI: 10.1002/art.38874).

URL Upon Publication: http://doi.wiley.com/10.1002/art.38874

Author Contact: To arrange an interview with Ane Rom, please contact Ane Rom; ane.lilleoere.rom@regionh.dkor +4522289088 at Research Unit Women and Children's Health, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Media Advisory

2014 ACR/ARHP Annual Meeting Information for Press


What: The 2014 ACR/ARHP Annual Meeting in Boston.

Thousands of rheumatologists and rheumatology health professionals are expected to attend this year's meeting, which will highlight the latest advances in rheumatology research.

Where: Boston Convention Center; Boston, Mass.

When: November 15-19, 2014

Registration: Advance registration is closed, however you may register onsite.

Policies: Please make sure to review our press guidelines at http://www.acrannualmeeting.org/Press as they may impact your ability to receive press credentials

Important information for this year's annual meeting: For more information about this year's annual meeting, visit http://www.acrannualmeeting.org/Press or contact Bonny Senkbeil at (404) 633-3777 or via e-mail at bsenkbeil@rheumatology.org.

About the Journal

Arthritis & Rheumatology is an official journal of the American College of Rheumatology (ACR) and covers all aspects of inflammatory disease. The American College of Rheumatology (http://www.rheumatology.org) is the professional organization whose members share a dedication to healing, preventing disability, and curing the more than 100 types of arthritis and related disabling and sometimes fatal disorders of the joints, muscles, and bones. Members include practicing physicians, research scientists, nurses, physical and occupational therapists, psychologists, and social workers. The journal is published by Wiley on behalf of the ACR. For more information, please visit http://wileyonlinelibrary.com/journal/art.

About Wiley

Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.

Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's website can be accessed at http://www.wiley.com.

Wiley

Related Rheumatoid Arthritis Articles from Brightsurf:

Reducing dementia in patients with rheumatoid arthritis
The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease modifying antirheumatic drugs (DMARDs) than in patients who receive conventional synthetic DMARDs, according to a new study.

Is rheumatoid arthritis two different diseases?
While disease activity improves over time for most rheumatoid arthritis (RA) patients, long-term outcomes only improve in RA patients with autoantibodies, according to a new study published this week in PLOS Medicine by Xanthe Matthijssen of Leiden University Medical Center, Netherlands, and colleagues.

Does the Mediterranean diet protect against rheumatoid arthritis?
Previous research has demonstrated a variety of health benefits associated with the Mediterranean diet, which is rich in olive oil, cereals, fruit and vegetables, fish, and a moderate amount of dairy, meat, and wine.

Reducing corticosteroid use in rheumatoid arthritis
Is the long-term use of glucocorticoids essential in people with chronic inflammatory diseases such as rheumatoid arthritis, or can early discontinuation prevent characteristic side effects?

Rheumatoid arthritis patients under treatment with methotrexate
Patients with rheumatoid arthritis (RA) often suffer from what is referred to as interstitial lung disease (ILD).

Rheumatoid arthritis -- can its onset be delayed or prevented?
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder that leads to significant health issues as well as high treatment costs.

Disease burden in osteoarthritis is similar to rheumatoid arthritis
Osteoarthritis (OA) has traditionally been viewed as a highly prevalent but milder condition when compared with rheumatoid arthritis (RA), and some may believe that it is part of a normal aging process requiring acceptance, not treatment.

Prospect of a new treatment for rheumatoid arthritis
An international research group led by Charité -- Universitätsmedizin Berlin has completed testing a new drug to treat rheumatoid arthritis.

Can rare lymphocytes combat rheumatoid arthritis?
Immunologists at Friedrich-Alexander-Universität Erlangen-Nürnberg have demonstrated that ILC2, a group of rare lymphoid cells, play a key role in the development of inflammatory arthritis.

Rheumatoid arthritis meets precision medicine
Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new multi-site study.

Read More: Rheumatoid Arthritis News and Rheumatoid Arthritis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.